Answers are grounded in this paper and cite their sources.
For patients developing ME/CFS after COVID-19 vaccination with insufficient or deficient vitamin D levels, appropriate vitamin D replacement therapy under medical guidance may lead to symptomatic relief. We are preparing a randomized controlled trial to evaluate the efficacy of vitamin D replacement therapy in individuals with ME/CFS who have developed vitamin D deficiency following COVID-19 infection or vaccination.
No takes yet. Share an insight, caveat, or question.
Kodama et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: